Financial Gravity Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Financial Gravity Asset Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Hold	0	–	–	–	1054
2021 Q3	$746K	Hold	1	–	–	0.35%	51
2021 Q2	$644K	Buy	+1	New	+$609	0.23%	72
2020 Q4	$2K	Buy	+4	New	+$2.28K	﹤0.01%	303
2019 Q4	$370K	Buy	53 +14	+36%	+$4.94K	0.25%	37
2019 Q3	$13K	Sell	39 -56	-59%	-$18.3K	0.01%	547
2019 Q2	$30K	Sell	95 -92	-49%	-$27.5K	0.02%	414
2019 Q1	$57K	Buy	+187	New	+$50.5K	0.05%	283

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Financial Gravity Asset Management's BIO Position: Q4 2023 in Review

Financial Gravity Asset Management held its Bio-Rad Laboratories Class A (BIO) position steady in Q4 2023 at 0 shares worth $178. The position accounts for ﹤0.01% of the portfolio, ranked #1054.

Financial Gravity Asset Management first reported a position in BIO in Q1 2019 and has held it in 7 quarters since. The position peaked at $746K in Q3 2021. 484 funds tracked by Wall St. Rank hold BIO as of Q4 2023.

Financial Gravity Asset Management held 0 shares of Bio-Rad Laboratories Class A worth $178 as of Q4 2023.
Financial Gravity Asset Management left its Bio-Rad Laboratories Class A share count unchanged in Q4 2023.
Bio-Rad Laboratories Class A made up ﹤0.01% of Financial Gravity Asset Management's portfolio in Q4 2023, its #1054 holding.
Financial Gravity Asset Management first reported a position in Bio-Rad Laboratories Class A in Q1 2019 and has held it in 7 quarters since.
Financial Gravity Asset Management's Bio-Rad Laboratories Class A position peaked at $746K in Q3 2021.
484 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2023.

Based on Financial Gravity Asset Management's 13F filing for Q4 2023, filed 15 Feb 2024.